Renaissance Technologies’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$149K Sell
116,639
-108,615
-48% -$139K ﹤0.01% 3230
2025
Q1
$225K Buy
225,254
+137,234
+156% +$137K ﹤0.01% 3044
2024
Q4
$80.1K Buy
88,020
+8,400
+11% +$7.64K ﹤0.01% 3318
2024
Q3
$119K Buy
79,620
+3,800
+5% +$5.7K ﹤0.01% 3229
2024
Q2
$53.3K Sell
75,820
-3,800
-5% -$2.67K ﹤0.01% 3283
2024
Q1
$76K Sell
79,620
-95,700
-55% -$91.3K ﹤0.01% 3417
2023
Q4
$195K Buy
175,320
+56,220
+47% +$62.5K ﹤0.01% 3141
2023
Q3
$224K Buy
119,100
+200
+0.2% +$376 ﹤0.01% 3048
2023
Q2
$427K Buy
118,900
+300
+0.3% +$1.08K ﹤0.01% 2959
2023
Q1
$400K Buy
118,600
+200
+0.2% +$675 ﹤0.01% 2992
2022
Q4
$184K Sell
118,400
-79,396
-40% -$123K ﹤0.01% 3446
2022
Q3
$269K Buy
197,796
+57,676
+41% +$78.4K ﹤0.01% 3256
2022
Q2
$307K Buy
140,120
+55,220
+65% +$121K ﹤0.01% 3447
2022
Q1
$271K Buy
+84,900
New +$271K ﹤0.01% 3514
2021
Q3
Sell
-140,100
Closed -$1.06M 3531
2021
Q2
$1.06M Sell
140,100
-39,900
-22% -$301K ﹤0.01% 2640
2021
Q1
$1.56M Buy
180,000
+106,900
+146% +$928K ﹤0.01% 2379
2020
Q4
$583K Sell
73,100
-22,900
-24% -$183K ﹤0.01% 2751
2020
Q3
$766K Buy
+96,000
New +$766K ﹤0.01% 2644
2019
Q2
Sell
-38,800
Closed -$294K 3571
2019
Q1
$294K Sell
38,800
-82,900
-68% -$628K ﹤0.01% 3100
2018
Q4
$983K Buy
+121,700
New +$983K ﹤0.01% 2577
2018
Q3
Sell
-230,300
Closed -$2.63M 3372
2018
Q2
$2.63M Buy
+230,300
New +$2.63M ﹤0.01% 2131